Aspen Pharmacare is considering more asset sales as part of its plans to reduce debt, says CEO Stephen Saad.
After the company reported results for the year to end-June this week, its shares rallied by more than 11% as the announcement also revealed debt had come down from R53.5bn to R38.9bn in the second half...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.